Unknown NA INTERVENTIONAL 1-arm NCT03239886

Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log

Sponsor: University of Sao Paulo General Hospital

Conditions Leukemia, Myeloid, Chronic-Phase

Updated 7 times since 2017 Last updated: Mar 22, 2018 Started: Dec 15, 2016 Primary completion: Aug 31, 2019 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Leukemia, Myeloid, Chronic-Phase and is currently ongoing. University of Sao Paulo General Hospital leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Mar 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Mar 2020 [monthly]

Active Not Recruiting NA

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Sep 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Sao Paulo General Hospital

Data source: University of Sao Paulo General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil